James C. Blair, Director, 10% Owner at Clovis Oncology, Inc. (CLVS), sold 4,200 shares at $24.44 ($103K) on 2013-03-04, disclosed to the SEC on 2013-03-06.
Open-market sale of $103k CLVS by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.44 | 417 | $10K | 9.9% |
| 2 | $24.69 | 2,132 | $53K | 51.0% |
| 3 | $24.51 | 1,651 | $40K | 39.2% |
| Total | $24.59 avg | 4,200 | $103K | 100% |
| Filing → |
| BNGO | BUY | 2018-08-27 | $92K | — | Filing → |
| CLVS | SELL | 2017-08-08 | $2.9M | — | Filing → |
| EVOK | SELL | 2016-05-27 | $1.6M | — | Filing → |